SERPINB6
Basic information
Region (hg38): 6:2948159-2972165
Previous symbols: [ "PI6", "DFNB91" ]
Links
Phenotypes
GenCC
Source:
- hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
- nonsyndromic genetic hearing loss (Moderate), mode of inheritance: AR
- autosomal recessive nonsyndromic hearing loss 91 (Definitive), mode of inheritance: AR
- autosomal recessive nonsyndromic hearing loss 91 (Strong), mode of inheritance: AR
- autosomal recessive nonsyndromic hearing loss 91 (Limited), mode of inheritance: AR
- autosomal recessive nonsyndromic hearing loss 91 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal recessive 91 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic | 20451170; 24963352 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (115 variants)
- not_specified (79 variants)
- Autosomal_recessive_nonsyndromic_hearing_loss_91 (9 variants)
- SERPINB6-related_disorder (7 variants)
- Rare_genetic_deafness (1 variants)
- Hearing_impairment (1 variants)
- Usher_syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SERPINB6 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004568.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 30 | 31 | ||||
missense | 74 | 12 | 90 | |||
nonsense | 3 | |||||
start loss | 1 | 1 | ||||
frameshift | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 1 | 4 | 76 | 42 | 4 |
Highest pathogenic variant AF is 0.0000415119
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SERPINB6 | protein_coding | protein_coding | ENST00000380520 | 6 | 23698 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000110 | 0.834 | 125714 | 0 | 34 | 125748 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0613 | 214 | 217 | 0.988 | 0.0000130 | 2528 |
Missense in Polyphen | 56 | 69.793 | 0.80237 | 902 | ||
Synonymous | -0.522 | 92 | 85.8 | 1.07 | 0.00000613 | 689 |
Loss of Function | 1.27 | 8 | 12.9 | 0.618 | 5.61e-7 | 172 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000560 | 0.000560 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000967 | 0.0000967 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the regulation of serine proteinases present in the brain or extravasated from the blood (By similarity). Inhibitor of cathepsin G, kallikrein-8 and thrombin. May play an important role in the inner ear in the protection against leakage of lysosomal content during stress and loss of this protection results in cell death and sensorineural hearing loss. {ECO:0000250, ECO:0000269|PubMed:10068683, ECO:0000269|PubMed:17761692, ECO:0000269|PubMed:20451170, ECO:0000269|PubMed:8136380, ECO:0000269|PubMed:8415716}.;
- Pathway
- Amoebiasis - Homo sapiens (human);Ectoderm Differentiation;Neutrophil degranulation;Dissolution of Fibrin Clot;Innate Immune System;Immune System;Hemostasis
(Consensus)
Intolerance Scores
- loftool
- 0.186
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.77
Haploinsufficiency Scores
- pHI
- 0.585
- hipred
- N
- hipred_score
- 0.247
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.494
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Serpinb6e
- Phenotype
Gene ontology
- Biological process
- sensory perception of sound;negative regulation of endopeptidase activity;neutrophil degranulation;cellular response to osmotic stress
- Cellular component
- extracellular region;extracellular space;nucleus;cytoplasm;cytosol;plasma membrane;secretory granule membrane;collagen-containing extracellular matrix;extracellular exosome;tertiary granule membrane;serine protease inhibitor complex;ficolin-1-rich granule membrane
- Molecular function
- protease binding;serine-type endopeptidase inhibitor activity